Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Prospective, Observational Study to Assess the Real World Effectiveness of Inclisiran (Leqvio®) in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05118230
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:18.523082+00:00
Published At
2024-08-07T00:00:00+00:00
Record Updated At
2024-08-07
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Primary Hypercholesterolemia", "Mixed Dyslipidemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-08-07"
protocolSection.identificationModule.nctId
"NCT05118230"
protocolSection.identificationModule.officialTitle
"A Prospective, Observational Study to Assess the Real World Effectiveness of Inclisiran (Leqvio\u00ae) in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Primary Hypercholesterolemia (protocolSection.conditionsModule.conditions)
  • Mixed Dyslipidemia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.